EPO Patents = 1

Forward Citations = 2

Loading Chart...

4 inventors (with patents filed for the assignee):

Jieyi Wang (5 out of 22 patents)

Yi Wu (3 out of 6 patents)

Yaolin Wang (1 out of 17 patents)

4. Liqun Dong (1 out of 3 patents)

5 patents: Sort by Forward Citations

1. 12024560 - Therapeutic agents and methods for enhancing immune responses in tumor microenvironment (2024-07-02),

2. 11976123 - Anti-CD40 antibodies and uses thereof (2024-05-07),

3. 11505615 - Anti-CD137 antibodies and uses thereof (2022-11-22),

4. 11203643 - Humanized anti-CD137 antibodies and uses thereof (2021-12-21),

5. 10913797 - Anti-PD-1 antibodies and therapeutic uses thereof (2021-02-09),

Lyvgen Biopharma Holdings Limited is a leading biotechnology company dedicated to the development of innovative therapies for a range of diseases. With a focus on precision medicine and cutting-edge technologies, Lyvgen is revolutionizing the field of biopharmaceuticals and improving the lives of patients around the world.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#104 in Grand Cayman

#143 in Cayman Islands

Grand Cayman, Cayman Islands

Lyvgen Biopharma Holdings Limited

Forward Citations = 2

4 inventors:

Jieyi Wang (5 out of 22 patents)

Yi Wu (3 out of 6 patents)

Yaolin Wang (1 out of 17 patents)

4. Liqun Dong (1 out of 3 patents)

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com